Published in Minerva Ginecol on June 14, 1990
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
Replacement of the Bacillus subtilis subtilisin structural gene with an In vitro-derived deletion mutation. J Bacteriol (1984) 5.03
Characterization of the spo0A locus and its deduced product. Proc Natl Acad Sci U S A (1985) 4.86
Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat Struct Biol (1999) 4.37
Cloning, sequencing, and secretion of Bacillus amyloliquefaciens subtilisin in Bacillus subtilis. Nucleic Acids Res (1983) 3.70
Cloning of the neutral protease gene of Bacillus subtilis and the use of the cloned gene to create an in vitro-derived deletion mutation. J Bacteriol (1984) 3.41
Chromosomal location of a Bacillus subtilis DNA fragment uniquely transcribed by sigma-28-containing RNA polymerase. J Bacteriol (1982) 2.82
Cloning structural gene sacB, which codes for exoenzyme levansucrase of Bacillus subtilis: expression of the gene in Escherichia coli. J Bacteriol (1983) 2.73
Localization of Bacillus subtilis sacU(Hy) mutations to two linked genes with similarities to the conserved procaryotic family of two-component signalling systems. J Bacteriol (1988) 2.71
Studies of sigma D-dependent functions in Bacillus subtilis. J Bacteriol (1990) 2.53
Paternal concentrations of dioxin and sex ratio of offspring. Lancet (2000) 2.47
Isolation of Bacillus subtilis genes from a charon 4A library. J Bacteriol (1981) 2.45
Identification of the pleiotropic sacQ gene of Bacillus subtilis. J Bacteriol (1986) 2.33
Effect of stage 0 sporulation mutations on subtilisin expression. J Bacteriol (1986) 2.31
Complete sequence of pSC101. Nucleic Acids Res (1984) 2.22
Cryptic deletions are a common finding in "balanced" reciprocal and complex chromosome rearrangements: a study of 59 patients. J Med Genet (2007) 2.21
De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase. J Virol (2000) 2.19
Biochemical and functional comparison of DNA polymerases alpha, delta, and epsilon from calf thymus. J Biol Chem (1991) 2.08
Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus. Nat Genet (1999) 2.05
Generation of large libraries of random mutants in Bacillus subtilis by PCR-based plasmid multimerization. Biotechniques (1997) 2.01
A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. N Engl J Med (1997) 1.97
Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med (2000) 1.94
Computational evidence in favor of a two-state, two-mode model of the retinal chromophore photoisomerization. Proc Natl Acad Sci U S A (2000) 1.92
Potyvirus proteins: a wealth of functions. Virus Res (2001) 1.85
Location of the targets of the hpr-97, sacU32(Hy), and sacQ36(Hy) mutations in upstream regions of the subtilisin promoter. J Bacteriol (1988) 1.74
Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost (1998) 1.71
Cloning and localization of the lepidopteran protoxin gene of Bacillus thuringiensis subsp. kurstaki. Proc Natl Acad Sci U S A (1982) 1.71
Effect of paraoxonase-1 polymorphism on clinical outcomes in patients treated with clopidogrel after an acute myocardial infarction. Clin Pharmacol Ther (2011) 1.67
Template/primer requirements and single nucleotide incorporation by hepatitis C virus nonstructural protein 5B polymerase. J Virol (2000) 1.63
Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J Clin Endocrinol Metab (1998) 1.63
Characterization of the levanase gene of Bacillus subtilis which shows homology to yeast invertase. Mol Gen Genet (1987) 1.58
Characterization and mapping of the Bacillus subtilis prtR gene. J Bacteriol (1987) 1.55
Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma. Thromb Haemost (1996) 1.51
[Precaution in the thrombolytic treatment of myocardial infarction]. Presse Med (1989) 1.40
[Severe early pulmonary embolism after blockage of the vena cava]. Presse Med (1994) 1.39
Activated protein C resistance: a comparison between two clotting assays and their relationship to the presence of the factor V Leiden mutation. Br J Haematol (1996) 1.39
Intrapericardial bronchogenic cyst: an unusual cause of CA 19-9 increase. Eur J Med (1992) 1.39
Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood (1995) 1.39
Enzymatic characterization of hepatitis C virus NS3/4A complexes expressed in mammalian cells by using the herpes simplex virus amplicon system. J Virol (1996) 1.38
Does factor V Asp79His (409 G/C) polymorphism influence factor V and APC resistance levels? J Thromb Haemost (2005) 1.38
Mutational analysis of bovine viral diarrhea virus RNA-dependent RNA polymerase. J Virol (1999) 1.37
Protein C deficiency: a database of mutations, 1995 update. On behalf of the Subcommittee on Plasma Coagulation Inhibitors of the Scientific and Standardization Committee of the ISTH. Thromb Haemost (1995) 1.36
Two TaqI RFLPs in the human von Willebrand factor gene. Nucleic Acids Res (1987) 1.33
p38alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha- to FoxO-dependent transcription. Cell Death Differ (2009) 1.30
Potyviral HC-Pro: a multifunctional protein. J Gen Virol (1996) 1.26
Correlation between Bacillus subtilis scoC phenotype and gene expression determined using microarrays for transcriptome analysis. J Bacteriol (2001) 1.26
Molecular cloning of the spo0B sporulation locus in bacteriophage lambda. J Bacteriol (1982) 1.23
Complete sequence of an IS element present in pSC101. Nucleic Acids Res (1981) 1.22
PvuII RFLP inside the human estrogen receptor gene. Nucleic Acids Res (1987) 1.22
The X-ray structure of a recombinant major urinary protein at 1.75 A resolution. A comparative study of X-ray and NMR-derived structures. Acta Crystallogr D Biol Crystallogr (2001) 1.20
Thyroid abnormalities during lithium treatment. Acta Psychiatr Scand (1991) 1.18
SCH 48973: a potent, broad-spectrum, antienterovirus compound. Antimicrob Agents Chemother (1997) 1.17
Neonatal screening for congenital adrenal hyperplasia. Arch Dis Child (1983) 1.17
Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients. J Clin Endocrinol Metab (2000) 1.16
Genetic and enzymic studies on the recombination process in Bacillus subtilis. Mol Gen Genet (1975) 1.16
Four different DNA helicases from calf thymus. J Biol Chem (1992) 1.10
Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice. Cancer Res (1998) 1.10
Preferential maternal derivation in inv dup(15): analysis of eight new cases. Hum Genet (1981) 1.08
Genetic contribution to idiopathic adult-onset blepharospasm and cranial-cervical dystonia. Eur Neurol (1993) 1.07
Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial. Pediatrics (2001) 1.06
Resistance of human nucleotide excision repair synthesis in vitro to p21Cdn1. Oncogene (1998) 1.06
Gene expression from viral RNA genomes. Plant Mol Biol (1996) 1.05
Gene deletion in an Italian haemophilia B subject. J Med Genet (1985) 1.05
A heminested polymerase chain reaction for the detection of Brazilian rabies isolates from vampire bats and herbivores. Mem Inst Oswaldo Cruz (2002) 1.04
Indocyanine green angiography in central serous chorioretinopathy. ICG angiography in CSC. Int Ophthalmol (1997) 1.04
Thyroid function in physiological aging and in centenarians: possible relationships with some nutritional markers. Metabolism (2002) 1.04
Calf thymus DNA polymerase delta independent of proliferating cell nuclear antigen (PCNA). Nucleic Acids Res (1989) 1.03
Nucleotide sequence of the outB locus of Bacillus subtilis and regulation of its expression. J Bacteriol (1987) 1.03
The frequency of oligonucleotides in mammalian genic regions. Comput Appl Biosci (1989) 1.03
Studies on transduction process by SPP1 phage. J Gen Virol (1978) 1.03
Effects of different types of exercise training followed by detraining on endothelium-dependent dilation in patients with recent myocardial infarction. Circulation (2009) 1.01
Do DNA polymerases delta and alpha act coordinately as leading and lagging strand replicases? FEBS Lett (1988) 1.01
Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol (2000) 0.99
Construction in vitro of hybrid plasmids carrying all the EcoRI fragments from lambdarifd18 DNA. Eur J Biochem (1979) 0.99
DNA polymerase switching: II. Replication factor C abrogates primer synthesis by DNA polymerase alpha at a critical length. J Mol Biol (2000) 0.99
Narcolepsy-cataplexy associated with precocious puberty. Neurology (2006) 0.99
Combined surgery and chemotherapy for the treatment of primary gastrointestinal intermediate- or high-grade non-Hodgkin's lymphomas. Br J Cancer (1989) 0.99
Influence of canine brain decomposition on laboratory diagnosis of rabies. Rev Soc Bras Med Trop (1999) 0.98
Protein C deficiency: a database of mutations. For the Protein C & S Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost (1993) 0.98
Enhanced superoxide production with no change of the antioxidant activity in gingival fluid of patients with chronic adult periodontitis. Free Radic Res Commun (1991) 0.97
Effects of diet-therapy on urinary protein excretion albuminuria and renal haemodynamic function in obese diabetic patients with overt nephropathy. Int J Obes (1989) 0.97
Co-localization of rare oligonucleotides and regulatory elements in mammalian upstream gene regions. J Mol Biol (1988) 0.97
[Guidelines for good clinical practice: prevention and treatment of venous thromboembolism in medical patients]. J Mal Vasc (2010) 0.96
Value of family history in identifying women at risk of venous thromboembolism during oral contraception: observational study. BMJ (2001) 0.96
Types, stability, and phenotypic consequences of chromosome rearrangements leading to interstitial telomeric sequences. J Med Genet (1993) 0.95
Changes of serum allopregnanolone levels in the first 2 years of life and during pubertal development. Pediatr Res (1999) 0.95
Solution structure of a recombinant mouse major urinary protein. Eur J Biochem (1999) 0.95
Esophageal leiomyomatosis in children: report of a case and review of the literature. Eur J Pediatr Surg (1998) 0.94
Clinical epidemiology of venous thromboembolic disease. Results of a French Multicentre Registry. Eur Heart J (1997) 0.94
Self-preventive oral behavior in an Italian university student population. J Clin Periodontol (2001) 0.94
Duplication of the short arm of chromosome 9. Analysis of five cases. Hum Genet (1982) 0.94
The p15 carboxyl-terminal proteolysis product of the human immunodeficiency virus type 1 reverse transcriptase p66 has DNA polymerase activity. Proc Natl Acad Sci U S A (1991) 0.94
Atypical deletions generated by mutated IS102 elements. Mol Gen Genet (1984) 0.93
Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII. J Thromb Haemost (2006) 0.93
A new approach to DNA polymerase kinetics. J Mol Biol (1979) 0.93
Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assay. Thromb Haemost (1993) 0.93
Clinical picture and management of congenital factor VII deficiency. Haemophilia (2004) 0.93
Novel splice isoforms of STRADalpha differentially affect LKB1 activity, complex assembly and subcellular localization. Cancer Biol Ther (2007) 0.93
Needle aspiration techniques in preoperative selection of patients with thyroid nodules: a long-term study. J Clin Oncol (1996) 0.92